Applied Biosensors has filed a notice of an exempt offering of securities to raise $7,999,999.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Applied Biosensors is raising $7,999,999.00 in new funding. Sources indicate that as part of senior management President, Prashant Tathireddy played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Applied Biosensors
Applied Biosensors (AB) is aspiring to be the worlds leader in the continuous biomarker monitoring industry with a revolutionary technology that is simple yet robust. At AB, were working to shape the future of biopharmaceutical production. Now, for the first time, a single sensor offered by AB can be used for continuous long term monitoring of multiple analytes. Our products are ready to use, are pre-calibrated and compatible with existing procedures & tools. We understand that measuring and monitoring production processes is critical in bio-manufacturing. For the very first time, AB Sense Technology provides: Continuous multi-analyte monitoring (glucose, pH, O2, temperature and more) Low-cost, single-use sensors High selectivity & reliability Minimal foreign material contact Wireless telemetry Weve built a whole new technology to getting you answers.
To learn more about Applied Biosensors, visit http://www.appliedbiosensors.com/
Contact:
Prashant Tathireddy, President
801-477-0570
https://www.linkedin.com/in/prashant-tathireddy-04354338/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.